Mechanisms of Disease: lessons from ethnicity in the role of triglyceride metabolism in ischemic heart disease

被引:17
作者
Godsland, Ian F.
Johnston, Desmond G.
Chaturvedi, Nishi
机构
[1] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England
来源
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 2007年 / 3卷 / 07期
关键词
atherogenic lipoproteins; ethnic differences; insulin resistance; ischemic heart disease; triglycerides; LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-B METABOLISM; CORONARY-ARTERY-DISEASE; STEAROYL-COA DESATURASE; VISCERAL ADIPOSE-TISSUE; RACIAL-DIFFERENCES; RISK-FACTORS; AFRICAN-AMERICAN; LIPASE GENE; PLASMA TRIGLYCERIDES;
D O I
10.1038/ncpendmet0530
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mean risk factor levels in various ethnic groups illustrate the potential importance of triglyceride metabolism in the risk for ischemic heart disease (IHD). Serum triglyceride concentrations are a surrogate for a range of potentially atherogenic disturbances in lipoprotein species, including increased concentrations of remnants of VLDL and chylomicron metabolism, increased small, dense LDL concentrations and reduced HDL concentrations. Differences between at-risk groups in lipoprotein profiles reflect alterations in the metabolism of triglycerides that might be greater than differences observed when only circulating triglyceride concentrations are measured. This atherogenic lipoprotein profile is typically found in association with increased visceral fat, insulin resistance and type 2 diabetes and might be a characteristic of Asian Indian ethnicity. By contrast, despite being relatively insulin resistant, Afro-Caribbean men in the UK have a low risk of IHD and lack the adverse lipoprotein profile. This could result from secretion of relatively large proportions of their VLDL as small, triglyceride-poor particles, levels of which are not augmented in response to loss of insulin action. These considerations re-endorse the potential importance of triglyceride metabolism in IHD and present opportunities for identifying useful areas in which drug targets for reducing IHD risk can be sought.
引用
收藏
页码:530 / 538
页数:9
相关论文
共 83 条
[1]   Population genetics -: Malaria susceptibility and CD36 mutation [J].
Aitman, TJ ;
Cooper, LD ;
Norsworthy, PJ ;
Wahid, FN ;
Gray, JK ;
Curtis, BR ;
McKeigue, PM ;
Kwiatkowski, D ;
Greenwood, BM ;
Snow, RW ;
Hill, AV ;
Scott, J .
NATURE, 2000, 405 (6790) :1015-1016
[2]   Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity [J].
Albu, JB ;
Curi, M ;
Shur, M ;
Murphy, L ;
Matthews, DE ;
Pi-Sunyer, FX .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 277 (03) :E551-E560
[3]   Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) [J].
Anand, SS ;
Yusuf, S ;
Vuksan, V ;
Devanesen, S ;
Teo, KK ;
Montague, PA ;
Kelemen, L ;
Yi, CL ;
Lonn, E ;
Gerstein, H ;
Hegele, RA ;
McQueen, M .
LANCET, 2000, 356 (9226) :279-284
[4]   Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans [J].
Anber, V ;
Griffin, BA ;
McConnell, M ;
Packard, CJ ;
Shepherd, J .
ATHEROSCLEROSIS, 1996, 124 (02) :261-271
[5]   AN UPDATED CORONARY RISK PROFILE - A STATEMENT FOR HEALTH-PROFESSIONALS [J].
ANDERSON, KM ;
WILSON, PWF ;
ODELL, PM ;
KANNEL, WB .
CIRCULATION, 1991, 83 (01) :356-362
[6]   Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia [J].
Attie, AD ;
Krauss, RM ;
Gray-Keller, MP ;
Brownlie, A ;
Miyazaki, M ;
Kastelein, JJ ;
Lusis, AJ ;
Stalenhoef, AFH ;
Stoehr, JP ;
Hayden, MR ;
Ntambi, JM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (11) :1899-1907
[7]   Triacylglycerol and coronary heart disease [J].
Austin, MA .
PROCEEDINGS OF THE NUTRITION SOCIETY, 1997, 56 (02) :667-670
[8]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[9]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[10]  
Bachorik PS, 1997, CLIN CHEM, V43, P2364